This study investigates the effectiveness, safety, and tolerability of an investigational medication administered subcutaneously compared to a placebo in adults with high-risk asthma. This study is designed for adults between the ages of 18 and 80 who have asthma but are not eligible for biologic treatments.Participants in the study will …
This study investigates the effects of an investigational medication on preventing or slowing lung function decline in adults with uncontrolled moderate to severe asthma. Participants in this study will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving standard care therapy.Participants …
This study investigates the long-term safety and effects of an investigational medication in adults with asthma. The purpose of this study is to evaluate how safe and effective the investigational medication is for adults who have completed previous related studies.Participants in the study will continue their treatment with the investigational …
The purpose of this study is to investigate the effectiveness of adding an investigational medication to a medium dose of inhaled corticosteroid and long-acting beta-agonist (ICS/LABA) in patients with uncontrolled asthma. Uncontrolled asthma means that patients are still experiencing frequent symptoms despite taking their current asthma medication. This study aims …
This study investigates the effects and safety of an investigational medication in children aged 2 to less than 6 years who have uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how well the medication works and how safe it is for long-term use in this age group. …
This study investigates pregnancy and infant outcomes in women exposed to an investigational medication during pregnancy. The study compares these outcomes with those of two other groups: pregnant women with similar health conditions who are not exposed to the investigational medication, and healthy pregnant women. The primary focus is on …
